We show that genetic and/or pharmacologic targeting of HIPK1 or MINK1 in human TFH cells inhibits their production of IL-21, a cytokine required for T cell-mediated help for B cell antibody production with specific links to autoantibody production in human SLE patients46. The gene discussed is IL21; the disease is systemic lupus erythematosus.